- Telehealth Study Recruiting Veterans Now
- USDA Delivers Immediate Relief to Farmers, Ranchers and Rural Communities Impacted by Recent Disasters
- Submit Nominations for Partnership for Quality Measurement (PQM) Committees
- Unleashing Prosperity Through Deregulation of the Medicare Program (Executive Order 14192) - Request for Information
- Dr. Mehmet Oz Shares Vision for CMS
- CMS Refocuses on its Core Mission and Preserving the State-Federal Medicaid Partnership
- Social Factors Help Explain Worse Cardiovascular Health among Adults in Rural Vs. Urban Communities
- Reducing Barriers to Participation in Population-Based Total Cost of Care (PB-TCOC) Models and Supporting Primary and Specialty Care Transformation: Request for Input
- Secretary Kennedy Renews Public Health Emergency Declaration to Address National Opioid Crisis
- Secretary Kennedy Renews Public Health Emergency Declaration to Address National Opioid Crisis
- 2025 Marketplace Integrity and Affordability Proposed Rule
- Rural America Faces Growing Shortage of Eye Surgeons
- NRHA Continues Partnership to Advance Rural Oral Health
- Comments Requested on Mobile Crisis Team Services: An Implementation Toolkit Draft
- Q&A: What Are the Challenges and Opportunities of Small-Town Philanthropy?
Lockdowns Reduced Mortality By 0.2%
Study finds lockdowns only reduced mortality by 0.2%. Researchers – Johns Hopkins University economics professor Steve Hanke, Lund University economics professor Lars Jonung, and special advisor at Copenhagen’s Center for Political Studies Jonas Herby – analyzed the effects of lockdown measures such as school shutdowns, business closures, and mask mandates on COVID-19 deaths. “We find little to no evidence that mandated lockdowns in Europe and the United States had a noticeable effect on COVID-19 mortality rates,” the researchers wrote. The researchers also examined shelter-in-place orders, finding that they reduced COVID-19 mortality by 2.9%. Read more.
People Could Lose Medicaid When Pandemic Ends
States expect the current federal public health emergency to expire this year, triggering a requirement that they must comb through their Medicaid rolls to see who is no longer eligible. With redeterminations for current Medicaid eligible placed on hold, Pennsylvania stands to see more than 400,000 lose coverage. Consumers typically lose coverage because their income increases, or they fail to submit the proper paperwork to prove eligibility. The PA Department of Human Services and the Pennsylvania Health Insurance Exchange, Pennie, have been working to identify those consumers who may lose Medicaid coverage and provide them with information on the availability of financial help if the enroll in Pennie. Read more.
2022 Federal Poverty Level Guidelines
Federal Poverty Level (FPL) guidelines are issued each year by the U.S. Department of Health and Human Services. They’re based on information gathered by the Census Bureau. The Bureau uses that data to calculate the total cost of essential resources used by an average person in a year. Federal poverty levels are used to determine eligibility for certain programs and benefits, including savings on Marketplace health insurance, and Medicaid and CHIP coverage. The Pennsylvania Health Law Project has created an Income and Resource Limit Chart for Medicaid and other health programs. View the full HHS chart.
Medicare Will Cover Free Over-the-Counter COVID-19 Tests
CMS Developing Initiative to Enable Access to Eight Free Over-the-Counter COVID-19 Tests for Medicare Beneficiaries in Early Spring
As part of the Biden-Harris Administration’s ongoing efforts to expand Americans’ access to free testing, people in either Original Medicare or Medicare Advantage will be able to get over-the-counter COVID-19 tests at no cost starting in early spring. Under the new initiative, Medicare beneficiaries will be able to access up to eight over-the-counter COVID-19 tests per month for free. Tests will be available through eligible pharmacies and other participating entities. This policy will apply to COVID-19 over-the-counter tests approved or authorized by the U.S. Food and Drug Administration (FDA).
This is the first time that Medicare has covered an over-the-counter test at no cost to beneficiaries. There are a number of issues that have made it difficult to cover and pay for over-the-counter COVID-19 tests. However, given the importance of expanding access to testing, CMS has identified a pathway that will expand access to free over-the-counter testing for Medicare beneficiaries. This new initiative will enable payment from Medicare directly to participating pharmacies and other participating entities to allow Medicare beneficiaries to pick up tests at no cost. CMS anticipates that this option will be available to people with Medicare in the early spring.
Until then, people with Medicare can access free tests through a number of channels established by the Biden-Harris Administration. Medicare beneficiaries can:
- Request four free over-the-counter tests for home delivery at covidtests.gov.
- Access COVID-19 tests through healthcare providers at over 20,000 free testing sites nationwide. A list of community-based testing sites can be found here.
- Access lab-based PCR tests and antigen tests performed by a laboratory when the test is ordered by a physician, non-physician practitioner, pharmacist, or other authorized health care professional at no cost. In addition to accessing a COVID-19 lab test ordered by a health care professional, people with Medicare can also already access one lab-performed test without an order, also without cost sharing, during the public health emergency.
In addition:
- Medicare Advantage plans may offer coverage and payment for over-the-counter COVID-19 tests as a supplemental benefit in addition to covering Medicare Part A and Part B benefits, so Medicare beneficiaries covered by Medicare Advantage should check with their plan to see if it includes such a benefit.
- All Medicare beneficiaries with Part B are eligible for the new benefit, whether enrolled in a Medicare Advantage plan or not.
For more information, please see these Frequently Asked Questions, https://www.cms.gov/files/document/covid-19-over-counter-otc-tests-medicare-frequently-asked-questions.pdf.
February is National Children’s Dental Health Month
This week is the start of National Children’s Dental Health Month (NCDHM). During February, oral health advocates across the country are raising awareness on the importance of children’s oral health and focusing on the theme, “Sealants Make Sense.” Free materials are available from the American Dental Association (ADA). Oral Health Watch is also hosting the “National Children’s Dental Health Month Tweet Chat” with several cohosts on February 10th at 2 pm ET. Participants are encouraged to follow @OralHealthWatch on Twitter and use #NCDHM and #KidsTeeth in any NCDHM-related tweets.
Click here to view the ADA’s free materials.
Click here to check out @OralHealthWatch on Twitter.
CDC Division of Oral Health New Email Subscriptions
The Centers for Disease Control and Prevention (CDC) Division of Oral Health has unveiled a new communication series of three topic-focused email subscriptions to educate, promote, and share information on various oral health subjects. The three new emails are General Updates from the Division of Oral Health, Infection Prevention & Control in Dental Settings, and CDC’s Dental Public Health Residency Program. The emails are intended for dental health care personnel, dental and dental public health students, advocates and educators, researchers, water operators and engineers, and anyone interested in oral health.
Click here to subscribe to the General Updates emails.
Click here to subscribe to the Infection Prevention & Control emails.
Click here to subscribe to the Dental Public Health Residency Program emails.
CMS Issues Funding Notice to Connect Kids to Coverage
The Centers for Medicare and Medicaid Services (CMS) is issuing a Notice of Funding Opportunity (NOFO) through the Connecting Kids to Coverage Helping Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017 (HEALTHY KIDS Act) 2022 Outreach and Enrollment Cooperative Agreements program.
The HEALTHY KIDS Act 2022 NOFO will make $49.4 million available, ranging between $500,000 to $1.5 million per awardee for a three-year period of performance, to fund efforts to increase the participation of eligible children, parents, and pregnant individuals in Medicaid and CHIP. This is the largest amount of funding CMS has ever made available for these outreach and enrollment awards. CMS aims to reach a broad range of stakeholder organizations eligible to apply for the awards, including encouraging applicants who will be targeting subgroups of children with lower than average health coverage rates (e.g. adolescents, Latino, AI/AN or children in rural areas), with a goal of having a robust applicant pool from which to choose funded entities.
Web Links:
Applications will be accepted through March 28, 2022. For more information, visit https://www.grants.gov/web/grants/view-opportunity.html?oppId=337485
Screening for Atrial Fibrillation
The U.S. Preventive Services Task Force (USPSTF) released their final recommendation statement on screening for atrial fibrillation that found that more research is needed to make a recommendation for or against screening. To view the recommendation, the evidence on which it is based, and a summary for clinicians, please go here. It can also be found in the January 25, 2022, online issue of the Journal of the American Medical Association.
Mitigation of Omicron in Homelessness
The U.S. Interagency Council on Homelessness released new federal guidance for communities to mitigate the impact of the Omicron variant among individuals experiencing homelessness. The Centers for Disease Control and Prevention (CDC), due to increased risk factors this population faces, recommend a 10-day isolation and quarantine – regardless of vaccination status.
FDA Warning on Transmucosal Buprenorphine Issued
The U.S. Food and Drug Administration (FDA) has released a warning on the use of transmucosal buprenorphine, a drug prescribed to treat opioid use disorder and pain. They warn that it may cause dental problems.